Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
9.01
-0.30 (-3.22%)
At close: Jul 31, 2026, 4:00 PM EDT
9.17
+0.16 (1.78%)
After-hours: Jul 31, 2026, 7:34 PM EDT
Kura Oncology Market Cap
Kura Oncology has a market cap or net worth of $799.86 million as of July 31, 2026. Its market cap has increased by 46.66% in one year.
Market Cap
799.86M
Enterprise Value
243.31M
1-Year Change
46.66%
Ranking
Category
Stock Price
$9.01
ChartMarket Cap Chart
Since November 5, 2015, Kura Oncology's market cap has increased from $113.70M to $799.86M, an increase of 603.48%. That is a compound annual growth rate of 19.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 799.86M | -11.53% |
| Dec 31, 2025 | 904.10M | 33.49% |
| Dec 31, 2024 | 677.30M | -36.58% |
| Dec 29, 2023 | 1.07B | 28.64% |
| Dec 30, 2022 | 830.20M | -10.90% |
| Dec 31, 2021 | 931.80M | -49.69% |
| Dec 31, 2020 | 1.85B | 197.24% |
| Dec 31, 2019 | 623.10M | 16.69% |
| Dec 31, 2018 | 534.00M | 15.51% |
| Dec 29, 2017 | 462.30M | 266.61% |
| Dec 30, 2016 | 126.10M | -29.75% |
| Dec 31, 2015 | 179.50M | 57.87% |
| Nov 5, 2015 | 113.70M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Odyssey Therapeutics | 877.60M |
| Theravance Biopharma | 874.34M |
| Arbutus Biopharma | 869.17M |
| Geron | 859.64M |
| Annexon | 856.90M |
| Omeros | 843.17M |
| Solid Biosciences | 826.98M |
| DBV Technologies | 812.86M |